Together, these findings indicate additional work is needed to establish how LRP5/6 genetic alterations contribute to prostate cancer growth, to gain new insight into how these Wnt co-receptors function, and to discover new therapeutic opportunities to treat this lethal disease. Here, LRP5 is linked to prostate cancer.